Popular on EntSun
- Could You Make a 2026 World Cup Squad? A New Free Tool Will Tell You Where You'd Sit on Any National Team's Bench in 90 Seconds - 223
- Milo3D.ai Launches Free AI 3D Model Generator That Turns Text and Images Into Game-Ready 3D Assets in Seconds - 171
- UK Financial Ltd Audits Full Ethereum Architecture Verifies Corporate Wallets and 19-Token Ecosystem Ahead of CoinMarketCap Filing for Global Ranking - 149
- Federal indictments bring new scrutiny to SPLC practices and highlight the real‑world impact of its designations on nonprofit groups, including NCFM - 146
- UK Financial Ltd Executes 100% Success Rate on All ERC-3643 Transfers to Coin Holders of MayaCat Regulated Security Token and Maya Preferred PRA - 126
- Blank Space: The Unofficial Taylor Swift Tribute Brings Eras Tour Magic To Cities Across America - 125
- WOA Entertainment Group Announces Captivating New EP 'The Fools Gold' by Ambient-Folk Project Leave the Bones - 121
- Boston Industrial Solutions Introduces New Natron® 310 Hyper White UV Ink for Enhanced Printing Performance - 120
- Speaker and Certified Coach Syrena N. Williams Debuts Powerful New Book on Healing, Identity, and Wholeness - 120
- Kaltra Expands Microchannel Water Coil Line for U.S. HVAC Market With New Corrosion-Resistant Tube Technology - 113
Similar on EntSun
- STO Foundation Launching June 29, 2026 to Advance the Global Tokenization Industry
- UK Financial Ltd Completes One Of The Most Extensive CoinMarketCap Supply Verification Packages For Maya Preferred PRA (MPRA)
- Beemok Hospitality Collection And KLH Group Announce Preferred Partnership
- Expanding Access to Mental Health Care in Toronto with Dr. Stephen Shainbart
- Dr. Stephen Shainbart Launches Expanded Mental Health Support for Anxiety and Depression in Toronto
- The $5 Million Man Still Begging: Incumbent Jimmy Panetta Hits Up Voters for More Cash Despite Massive War Chest
- $150+ Million Contracted Backlog, Strategic Acquisitions Adding Millions In Recurring Revenue, Improving Margins & A Clear Path Toward Profitability
- Record Revenue Growth, AI-Driven Healthcare Innovation, Expanding Proprietary Brand and Targeting $200 Million Revenue By 2029: Cosmos Health Inc
- Mr. Hospital Bed Showcases the Best Hospital Bed and Air Mattress for Bed Sores for 2026
- K2 Integrity Acquires RiskFront AI to Deliver AI Automation for Financial Crime Compliance and Risk Operations
FivepHusion Announces Strategic Collaboration with Treehill Partners and Syneos Health
EntSun News/10987091
SYDNEY, May 26, 2023 ~ FivepHusion, a clinical-stage biotechnology company, has announced a collaboration with Treehill Partners and Syneos Health® to develop and bring a novel, enhanced chemotherapeutic product to market.
Treehill Partners, a New York-based strategic and financial advisory firm specializing in healthcare industry transactions, will provide FivepHusion with integrated business development, operational, strategic and transactional expertise. Syneos Health will support FivepHusion's integrated clinical development and commercialization capabilities. This collaboration is designed to strategically and optimally progress the development and commercialization of FivepHusion's enhanced chemotherapeutic formulation Deflexifol™ in global markets.
More on EntSun News
Dr. Christian Toouli, CEO & Managing Director of FivepHusion said: "This is a very exciting time for FivepHusion. We are at a crucial stage in our growth strategy. By collaborating with Treehill Partners and Syneos Health, we believe we are positioned to successfully bring our development work on Deflexifol™ to global markets."
Christian Tucat, Chief Business Officer of Syneos Health added: "Leveraging our deep therapeutic and global expertise, Syneos Health is pleased to contribute to accelerating the clinical development and commercialization of this important new therapy."
Ali Pashazadeh, Partner & Co-founder of Treehill Partners commented: "This collaboration represents a new model of integrated services across disciplines designed to allow US and non-US emerging players to play a key role on the global stage."
The collaboration between these three industry leaders is intended to maximize progress on the development of Deflexifol™ and quickly bring innovative oncology medicines to patients in need.
Treehill Partners, a New York-based strategic and financial advisory firm specializing in healthcare industry transactions, will provide FivepHusion with integrated business development, operational, strategic and transactional expertise. Syneos Health will support FivepHusion's integrated clinical development and commercialization capabilities. This collaboration is designed to strategically and optimally progress the development and commercialization of FivepHusion's enhanced chemotherapeutic formulation Deflexifol™ in global markets.
More on EntSun News
- Allstream Energy Partners Announce Media Partnership with the 2026 EPC Show - The Energy Projects Conference
- STO Foundation Launching June 29, 2026 to Advance the Global Tokenization Industry
- Delirious After Dark - The Most Unpredictable Show In Las Vegas
- Bula Buddy Launches to Connect the Growing Global Kava Community
- 10th Anniversary Meadowlands Comedy Club Showscase Next to FIFA Games, MetLife
Dr. Christian Toouli, CEO & Managing Director of FivepHusion said: "This is a very exciting time for FivepHusion. We are at a crucial stage in our growth strategy. By collaborating with Treehill Partners and Syneos Health, we believe we are positioned to successfully bring our development work on Deflexifol™ to global markets."
Christian Tucat, Chief Business Officer of Syneos Health added: "Leveraging our deep therapeutic and global expertise, Syneos Health is pleased to contribute to accelerating the clinical development and commercialization of this important new therapy."
Ali Pashazadeh, Partner & Co-founder of Treehill Partners commented: "This collaboration represents a new model of integrated services across disciplines designed to allow US and non-US emerging players to play a key role on the global stage."
The collaboration between these three industry leaders is intended to maximize progress on the development of Deflexifol™ and quickly bring innovative oncology medicines to patients in need.
Filed Under: Business
0 Comments
Latest on EntSun News
- Brilliant Minds to Gather in Fort Worth for National Mensa Event
- UK Financial Ltd Completes One Of The Most Extensive CoinMarketCap Supply Verification Packages For Maya Preferred PRA (MPRA)
- Data Tiles Strengthens U.S. Presence with Chief Revenue Officer John Goode
- Haven Media Solutions Offers Web Design and PPC Services in Atlanta GA
- Clean Comedy Kings Takes Over Ross Ragland Theater Klamath Falls Sat July 11
- Actress Zaria Imani Primer Marks Final Season of The Chi with Full-Circle Moment
- Clean Comedy Kings Comes To Weaverville Friday July 10
- Alaska Picture Cars Opens Statewide Platform for Authentic Movie Car Rentals and Cinema Vehicles
- TREND Network Announces Miami Based Reality Series "Coming Up Miami" Premiering July 1
- NVUS - Fashion-Focused Social Platform
- Indiana Picture Cars Opens as the Premier Source for Picture Car Rentals in Indiana
- Kingsmen Shakespeare Festival Celebrates 30 Years
- Beemok Hospitality Collection And KLH Group Announce Preferred Partnership
- Expanding Access to Mental Health Care in Toronto with Dr. Stephen Shainbart
- Dr. Stephen Shainbart Launches Expanded Mental Health Support for Anxiety and Depression in Toronto
- Equipment Leases, Inc. Launches Updated Family Office Equipment Financing Page
- Dr. Samuel Waymon is coming to UC Santa Cruz
- Anjalts To Release Emotionally Unfiltered Single 'Crying in the Dark' on June 12
- Houston Teen Country Duo Maddy & Colton to Perform on Main Stage at 2026 FIFA World Cup Houston Fan Festival
- The $5 Million Man Still Begging: Incumbent Jimmy Panetta Hits Up Voters for More Cash Despite Massive War Chest